ANGLE (LON:AGL) Receives Buy Rating from Berenberg Bank

ANGLE (LON:AGL)‘s stock had its “buy” rating reissued by Berenberg Bank in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. They currently have a GBX 70 ($0.86) price objective on the stock. Berenberg Bank’s price target would suggest a potential upside of 400.00% from the stock’s current price.

ANGLE Trading Down 9.7 %

AGL opened at GBX 14 ($0.17) on Wednesday. The stock has a market capitalization of £36.48 million, a PE ratio of -154.08 and a beta of 0.20. The firm’s fifty day moving average price is GBX 14.41 and its 200 day moving average price is GBX 14.05. The company has a debt-to-equity ratio of 14.26, a current ratio of 7.51 and a quick ratio of 6.18. ANGLE has a 12-month low of GBX 9.07 ($0.11) and a 12-month high of GBX 37.40 ($0.46).

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.